[Ecstasy: a review of scientific literature about MDMA].

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Medicina clínica (Ed. impresa)

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 12716545
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Information on "Ecstasy".

  2006cited by this paper
• Effect of ascorbate and cysteine on the 3,4-methylenedioxymethamphetamine-induced depletion of brain serotonin

  2005cited by this paper
• In brief

  2002cited by this paper
• [Designer drugs].

  2002cited by this paper
• Severe Dopaminergic Neurotoxicity in Primates After a Common Recreational Dose Regimen of MDMA ("Ecstasy")

  2002cited by this paper
• 3,4-Methylenedioxymethamphetamine (Ecstasy)-Induced Learning and Memory Impairments Depend on the Age of Exposure during Early Development

  2001cited by this paper
• The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs.

  2001cited by this paper
• Caveat Emptor: Editors Beware

  2001cited by this paper
• Psychiatric effects of cannabis

  2001cited by this paper
• Alterations in diurnal and nocturnal locomotor activity in rats treated with a monoamine-depleting regimen of methamphetamine or 3,4-methylenedioxymethamphetamine

  2001cited by this paper
• Effects of repeated doses of MDMA ("ecstasy") on cell-mediated immune response in humans.

  2001cited by this paper
• Ecstasy experts want realistic messages.

  2001cited by this paper
• Acute effects of 3,4-methylenedioxymethamphetamine alone and in combination with ethanol on the immune system in humans.

  2001cited by this paper
• Is hyperthermia the triggering factor for hepatotoxicity induced by 3,4-methylenedioxymethamphetamine (ecstasy)? An in vitro study using freshly isolated mouse hepatocytes

  2001cited by this paper
• The mechanisms involved in the long‐lasting neuroprotective effect of fluoxetine against MDMA (‘ecstasy’)‐induced degeneration of 5‐HT nerve endings in rat brain

  2001cited by this paper
• An “Accidental” Acute Psychosis with Ecstasy Use

  2001cited by this paper
• Use of amphetamine by recreational users of ecstasy (MDMA) is associated with reduced striatal dopamine transporter densities: a [123I]β-CIT SPECT study – preliminary report

  2001cited by this paper
• Fatal 4-MTA intoxication: development of a liquid chromatographic-tandem mass spectrometric assay for multiple matrices.

  2001cited by this paper
• Chemical analysis of ecstasy pills.

  2000cited by this paper
• Non-linear pharmacokinetics of MDMA ('ecstasy') in humans.

  2000cited by this paper
• Ecstasy-induced toxicity in rat liver.

  2000cited by this paper
• Direct effects of 3,4‐methylenedioxymethamphetamine (MDMA) on serotonin or dopamine release and uptake in the caudate putamen, nucleus accumbens, substantia nigra pars reticulata, and the dorsal raphé nucleus slices

  2000cited by this paper
• Raves: a review of the culture, the drugs and the prevention of harm.

  2000cited by this paper
• The serotonin uptake inhibitor citalopram reduces acute cardiovascular and vegetative effects of 3, 4-methylenedioxymethamphetamine (‘Ecstasy’) in healthy volunteers

  2000cited by this paper
• Cardiovascular effects of 3,4-methylenedioxymethamphetamine. A double-blind, placebo-controlled trial.

  2000cited by this paper
• Long term psychiatric and cognitive effects of MDMA use.

  2000cited by this paper
• Is MDMA (‘Ecstasy’) Neurotoxic in Humans? An Overview of Evidence and of Methodological Problems in Research

  2000cited by this paper
• Impaired cognitive performance in drug free users of recreational ecstasy (MDMA)

  2000cited by this paper
• Pharmacology of MDMA in Humans

  2000cited by this paper
• Acute psychological and physiological effects of MDMA ("Ecstasy") after haloperidol pretreatment in healthy humans.

  2000cited by this paper
• ‘Is MDMA a Human Neurotoxin?’:Diverse Views from the Discussants

  2000cited by this paper
• Immunomodulating Activity of MDMA

  2000cited by this paper
• Aortic dissection after ingestion of "ecstasy" (MDMA).

  2000cited by this paper
• Cognitive performance amongst recreational users of "ecstasy

  2000cited by this paper
• Working memory deficits in current and previous users of MDMA ('ecstasy').

  2000cited by this paper
• Review article: mechanisms and management of hepatotoxicity in ecstasy (MDMA) and amphetamine intoxications

  1999cited by this paper
• Cardiovascular and neuroendocrine effects and pharmacokinetics of 3, 4-methylenedioxymethamphetamine in humans.

  1999cited by this paper
• Analysis of illicit ecstasy tablets: implications for clinical management in the accident and emergency department.

  1999cited by this paper
• Ecstasy (MDMA) dependence.

  1999cited by this paper
• Life-threatening interactions between HIV-1 protease inhibitors and the illicit drugs MDMA and gamma-hydroxybutyrate.

  1999cited by this paper
• Thrombotic thrombocytopenic purpura after Ecstasy-induced acute liver failure.

  1999cited by this paper
• Memory deficits associated with recreational use of “ecstasy” (MDMA)

  1999cited by this paper
• Glutathione and N-acetylcysteine conjugates of alpha-methyldopamine produce serotonergic neurotoxicity: possible role in methylenedioxyamphetamine-mediated neurotoxicity.

  1999cited by this paper
• Behavioural analysis of the acute and chronic effects of MDMA treatment in the rat

  1999cited by this paper
• Congenital anomalies after prenatal ecstasy exposure.

  1999cited by this paper
• Fatal multi-organ failure after suicidal overdose with MDMA, `Ecstasy': case report and review of the literature

  1999cited by this paper
• 3,4-Methylenedioxymethamphetamine (ecstasy)-induced hepatotoxicity: effect on cytosolic calcium signals in isolated hepatocytes.

  1999cited by this paper
• Cognitive performance in (±) 3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”) users: a controlled study

  1999cited by this paper
• Hyponatraemia and seizures after ecstasy use

  1999cited by this paper
• 3,4-Methylenedioxy analogues of amphetamine: defining the risks to humans.

  1999cited by this paper
• Reduced in vivo binding to the serotonin transporter in the cerebral cortex of MDMA (‘ecstasy’) users

  1999cited by this paper
• Parkinsonism after taking ecstasy.

  1999cited by this paper
• Ecstasy-induced renal vasculitis.

  1999cited by this paper
• Death from hyponatraemia-induced cerebral oedema associated with MDMA ("Ecstasy") use.

  1999cited by this paper
• Memory impairment in abstinent MDMA ("Ecstasy") users

  1998cited by this paper
• Ecstasy Pimples – A New Facial Dermatosis

  1998cited by this paper
• Ecstasy: a common cause of severe acute hepatotoxicity.

  1998cited by this paper
• Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance

  1998cited by this paper
• "Saturday night fever": ecstasy related problems in a London accident and emergency department.

  1998cited by this paper
• Death by "ecstasy": the serotonin syndrome?

  1998cited by this paper
• Prenatal exposure to amphetamines. Risks and adverse outcomes in pregnancy.

  1998cited by this paper
• Hyponatraemia, seizures and stupor associated with ecstasy ingestion in a female.

  1998cited by this paper
• Cognitive performance in recreational users of MDMA or 'ecstasy': evidence for memory deficits

  1998cited by this paper
• Amphetamine derivative fatalities in South Australia--is "Ecstasy" the culprit?

  1998cited by this paper
• Low-dose MDMA ("ecstasy") induces vasopressin secretion.

  1998cited by this paper
• Retinal haemorrhage caused by “ecstasy”

  1998cited by this paper
• [Ecstasy: idiosyncrasy, overdosage or collateral effects].

  1998cited by this paper
• Positron emission tomographic evidence of toxic effect of MDMA ("Ecstasy") on brain serotonin neurons in human beings.

  1998cited by this paper
• Small Changes in Ambient Temperature Cause Large Changes in 3,4-Methylenedioxymethamphetamine (MDMA)-Induced Serotonin Neurotoxicity and Core Body Temperature in the Rat

  1998cited by this paper
• [Toxicity of ecstasy].

  1998cited by this paper
• Recent paramethoxyamphetamine deaths.

  1998cited by this paper
• Serotonergic function after (±)3,4‐methylene-dioxymethamphetarnine (‘Ecstasy’) in humans

  1998cited by this paper
• MDMA ('ecstasy') consumption in the context of polydrug abuse: a report on 150 patients.

  1998cited by this paper
• Hyponatraemia, water intoxication and ‘ecstasy’

  1997cited by this paper
• Hyponatraemic coma after ecstasy ingestion.

  1997cited by this paper
• Relapse of depression after rapid depletion of tryptophan.

  1997cited by this paper
• Accidental intoxication with methylene dianiline p,p'-diaminodiphenylmethane: acute liver damage after presumed ecstasy consumption.

  1997cited by this paper
• MDMA induced hyperthermia: a survivor with an initial body temperature of 42.9 degrees C.

  1997cited by this paper
• 2,5-Bis-(glutathion-S-yl)-alpha-methyldopamine, a putative metabolite of (+/-)-3,4-methylenedioxyamphetamine, decreases brain serotonin concentrations.

  1997cited by this paper
• A study of the neurotoxic effect of MDMA (‘ecstasy’) on 5‐HT neurones in the brains of mothers and neonates following administration of the drug during pregnancy

  1997cited by this paper
• Hyponatraemia and death after “ecstasy” ingestion

  1997cited by this paper
• Spontaneous pneumomediastinum and Ecstasy abuse.

  1997cited by this paper
• MDMA induced hyperthermia: Report of a fatality and review of current therapy

  1996cited by this paper
• Ecstasy intoxication: an overlap between serotonin syndrome and neuroleptic malignant syndrome.

  1996cited by this paper
• Chronic ecstasy (3,4-methylenedioxymetamphetamine) abuse: a recurrent and unpredictable cause of severe acute hepatitis.

  1996cited by this paper
• Effects of ecstasy on aldosterone secretion in the rat in vivo and in vitro.

  1996cited by this paper
• Pathology of deaths associated with "ecstasy" and "eve" misuse.

  1996cited by this paper
• Adverse symptomatology and suicide associated with the use of methylenedioxymethamphetamine (MDMA; "Ecstasy").

  1996cited by this paper
• Ecstasy induced pneumomediastinum.

  1996cited by this paper
• Acute liver damage and ecstasy ingestion.

  1996cited by this paper
• Behavioral and neurochemical effects of chronic methylenedioxymethamphetamine (MDMA) treatment in rhesus monkeys.

  1995cited by this paper
• Psychobiologic effects of 3,4-methylenedioxymethamphetamine in humans: methodological considerations and preliminary observations.

  1995cited by this paper
• Hyperthermia following MDMA administration in rats: effects of ambient temperature, water consumption, and chronic dosing.

  1995cited by this paper
• Acute renal failure due to accelerated hypertension following ingestion of 3,4-methylenedioxymethamphetamine ('ecstasy').

  1995cited by this paper
• Hepatotoxicity and accelerated fibrosis following 3,4-methylenedioxymetamphetamine ("ecstasy") usage.

  1995cited by this paper
• Ecstasy induced hepatitis mimicking viral hepatitis.

  1995cited by this paper
• Diversity of Psychopathology Associated with use of 3,4-Methylenedioxymethamphetamine (‘Ecstasy’)

  1994cited by this paper
• Malignant hyperpyrexia in an MDMA ("Ecstasy") abuser.

  1994cited by this paper
• Serotonin Neurotoxicity after (±)3,4-Methylenedioxymethamphetamine (MDMA; “Ecstasy”): A Controlled Study in Humans

  1994cited by this paper
• MDMA ("ecstasy") abuse: psychopathological features and craving for chocolate: a case series.

  1994cited by this paper

• Implicación de la vía kinurenina en los efectos inmediatos y a largo plazo inducidos por 3,4-metilendioximetanfetamina (MDMA, éxtasis) en cerebro de rata

  2019cites this paper
• ["Liquid ecstasy" (GHB): a recreational drug? Bio-psycho-social clinical profile of the consumer and some therapeutic proposals].

  2004cites this paper